Dfzljdn9uc3pi.cloudfront.net
Supplementary Table 1. Temporal scale showing the respective period when a new antibiotic has been discovered, main period of clinical usage and the approximate year when a first resistance to that compound has been documented. The table is partially adapted from multiple sourcesPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DbGF0d29ydGh5PC9BdXRob3I+PFllYXI+MjAwNzwvWWVh
cj48UmVjTnVtPjY2PC9SZWNOdW0+PERpc3BsYXlUZXh0PihDbGF0d29ydGh5IGV0IGFsIDIwMDcs
IFRvcm9rIGV0IGFsIDIwMDksIHZhbiBIb2VrIGV0IGFsIDIwMTEpPC9EaXNwbGF5VGV4dD48cmVj
b3JkPjxyZWMtbnVtYmVyPjY2PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO
IiBkYi1pZD0id3p3OWZzd2ZwdzA5eDdlcHp3ZHYyd3BydnR6cnJkdHNhdDVwIiB0aW1lc3RhbXA9
IjE0OTk0Mjk2NzAiPjY2PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJu
YWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5D
bGF0d29ydGh5LCBBLiBFLjwvYXV0aG9yPjxhdXRob3I+UGllcnNvbiwgRS48L2F1dGhvcj48YXV0
aG9yPkh1bmcsIEQuIFQuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFk
ZHJlc3M+RGVwYXJ0bWVudCBvZiBNb2xlY3VsYXIgQmlvbG9neSBhbmQgQ2VudGVyIGZvciBDb21w
dXRhdGlvbmFsIGFuZCBJbnRlZ3JhdGl2ZSBCaW9sb2d5LCBNYXNzYWNodXNldHRzIEdlbmVyYWwg
SG9zcGl0YWwsIDE4NSBDYW1icmlkZ2UgU3QuLCBCb3N0b24sIE1hc3NhY2h1c2V0dHMgMDIxMTQs
IFVTQS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5UYXJnZXRpbmcgdmlydWxlbmNlOiBh
IG5ldyBwYXJhZGlnbSBmb3IgYW50aW1pY3JvYmlhbCB0aGVyYXB5PC90aXRsZT48c2Vjb25kYXJ5
LXRpdGxlPk5hdCBDaGVtIEJpb2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNh
bD48ZnVsbC10aXRsZT5OYXQgQ2hlbSBCaW9sPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFn
ZXM+NTQxLTg8L3BhZ2VzPjx2b2x1bWU+Mzwvdm9sdW1lPjxudW1iZXI+OTwvbnVtYmVyPjxrZXl3
b3Jkcz48a2V5d29yZD5BbnRpLUluZmVjdGl2ZSBBZ2VudHMvKnBoYXJtYWNvbG9neS90aGVyYXBl
dXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QmFjdGVyaWFsIEFkaGVzaW9uL2RydWcgZWZmZWN0
czwva2V5d29yZD48a2V5d29yZD5EcnVnIERlbGl2ZXJ5IFN5c3RlbXM8L2tleXdvcmQ+PGtleXdv
cmQ+R2VuZXMsIEJhY3RlcmlhbDwva2V5d29yZD48a2V5d29yZD5RdW9ydW0gU2Vuc2luZy9kcnVn
IGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+VmlydWxlbmNlLypkcnVnIGVmZmVjdHMvZ2VuZXRp
Y3M8L2tleXdvcmQ+PGtleXdvcmQ+VmlydWxlbmNlIEZhY3RvcnMvKmFudGFnb25pc3RzICZhbXA7
IGluaGliaXRvcnM8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwNzwveWVhcj48
cHViLWRhdGVzPjxkYXRlPlNlcDwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1NTIt
NDQ1MCAoUHJpbnQpJiN4RDsxNTUyLTQ0NTAgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVt
PjE3NzEwMTAwPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwczov
L3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xNzcxMDEwMDwvdXJsPjwvcmVsYXRlZC11cmxz
PjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTAzOC9uY2hlbWJpby4yMDA3LjI0
PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj52
YW4gSG9lazwvQXV0aG9yPjxZZWFyPjIwMTE8L1llYXI+PFJlY051bT42NzwvUmVjTnVtPjxyZWNv
cmQ+PHJlYy1udW1iZXI+Njc8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4i
IGRiLWlkPSJ3enc5ZnN3ZnB3MDl4N2VwendkdjJ3cHJ2dHpycmR0c2F0NXAiIHRpbWVzdGFtcD0i
MTQ5OTQyOTc0NiI+Njc8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5h
bCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPnZh
biBIb2VrLCBBLiBILjwvYXV0aG9yPjxhdXRob3I+TWV2aXVzLCBELjwvYXV0aG9yPjxhdXRob3I+
R3VlcnJhLCBCLjwvYXV0aG9yPjxhdXRob3I+TXVsbGFueSwgUC48L2F1dGhvcj48YXV0aG9yPlJv
YmVydHMsIEEuIFAuPC9hdXRob3I+PGF1dGhvcj5BYXJ0cywgSC4gSi48L2F1dGhvcj48L2F1dGhv
cnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5MYWJvcmF0b3J5IGZvciBab29ub3NlcyBh
bmQgRW52aXJvbm1lbnRhbCBNaWNyb2Jpb2xvZ3ksIENlbnRyZSBmb3IgSW5mZWN0aW91cyBEaXNl
YXNlIENvbnRyb2wsIE5hdGlvbmFsIEluc3RpdHV0ZSBvZiBQdWJsaWMgSGVhbHRoIGFuZCB0aGUg
RW52aXJvbm1lbnQgVXRyZWNodCwgTmV0aGVybGFuZHMuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48
dGl0bGU+QWNxdWlyZWQgYW50aWJpb3RpYyByZXNpc3RhbmNlIGdlbmVzOiBhbiBvdmVydmlldzwv
dGl0bGU+PHNlY29uZGFyeS10aXRsZT5Gcm9udCBNaWNyb2Jpb2w8L3NlY29uZGFyeS10aXRsZT48
L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Gcm9udCBNaWNyb2Jpb2w8L2Z1bGwtdGl0
bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4yMDM8L3BhZ2VzPjx2b2x1bWU+Mjwvdm9sdW1lPjxrZXl3
b3Jkcz48a2V5d29yZD5hY3F1aXJlZDwva2V5d29yZD48a2V5d29yZD5hbnRpYmlvdGljczwva2V5
d29yZD48a2V5d29yZD5hbnRpbWljcm9iaWFsIHJlc2lzdGFuY2UgbWVjaGFuaXNtczwva2V5d29y
ZD48a2V5d29yZD5tb2JpbGUgZ2VuZXRpYyBlbGVtZW50czwva2V5d29yZD48L2tleXdvcmRzPjxk
YXRlcz48eWVhcj4yMDExPC95ZWFyPjwvZGF0ZXM+PGlzYm4+MTY2NC0zMDJYIChFbGVjdHJvbmlj
KSYjeEQ7MTY2NC0zMDJYIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMjA0NjE3Mjwv
YWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cHM6Ly93d3cubmNiaS5u
bG0ubmloLmdvdi9wdWJtZWQvMjIwNDYxNzI8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGN1
c3RvbTI+UE1DMzIwMjIyMzwvY3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMzM4
OS9mbWljYi4yMDExLjAwMjAzPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0Np
dGU+PENpdGU+PEF1dGhvcj5Ub3JvazwvQXV0aG9yPjxZZWFyPjIwMDk8L1llYXI+PFJlY051bT42
ODwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+Njg8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5
cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJ3enc5ZnN3ZnB3MDl4N2VwendkdjJ3cHJ2dHpycmR0c2F0
NXAiIHRpbWVzdGFtcD0iMTQ5OTQyOTk2NSI+Njg8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5
cGUgbmFtZT0iQm9vayI+NjwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9y
PlRvcm9rLCBFLjwvYXV0aG9yPjxhdXRob3I+TW9yYW4sIEUuPC9hdXRob3I+PGF1dGhvcj5Db29r
ZSwgRi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+T3hm
b3JkIEhhbmRib29rIG9mIEluZmVjdGlvbnMgRGlzZWFzZXMgYW5kIE1pY3JvYmlvbG9neTwvdGl0
bGU+PC90aXRsZXM+PGRhdGVzPjx5ZWFyPjIwMDk8L3llYXI+PC9kYXRlcz48cHViLWxvY2F0aW9u
Pk94Zm9yZDwvcHViLWxvY2F0aW9uPjxwdWJsaXNoZXI+T3hmb3JkIFVuaXZlcnNpdHkgUHJlc3M8
L3B1Ymxpc2hlcj48aXNibj45NzgwMTk4NTY5MjUxPC9pc2JuPjx1cmxzPjwvdXJscz48ZWxlY3Ry
b25pYy1yZXNvdXJjZS1udW0+MTAuMTA5My9tZWQvOTc4MDE5ODU2OTI1MS4wMDEuMDAwMTwvZWxl
Y3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DbGF0d29ydGh5PC9BdXRob3I+PFllYXI+MjAwNzwvWWVh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=
ADDIN EN.CITE.DATA (Clatworthy et al 2007, Torok et al 2009, van Hoek et al 2011), including national and international guidelines, as well as personal communication with Swiss and French doctors. Antibiotics (class)Discovery (year)Period of usagea Resistance (year)bSulfonamides19301940-19601970-1985c2005-20171940Tetracycline19481955-19701953Penicillin19291930-19702005-2017d1947Methicillin19601960-20171962Ampicillin19621965-2017e1974Cephalosporins1960-1970f1965-2017g1970Vancomycine19571970-19952000-2017h1988Streptomycin (Aminoglycosides)19431946-19601980-20001958Chloramphenicol19471950-19701958 Erythromycin (Macrolides)19521995-2010i 1988Norfloxacin (Quinolones)19791986-1995j1981Ciprofloxacin (Quinolones)19871990-2005k1988Linezolid20002010-20152004Daptomycin20042012-20172005Clindamycin (Lincosamides)19601960-1975l1964aEstimates made for Europe; in some sub-Saharan countries, due to the difficulties of access some antibiotics (such as chloramphenicol and streptomycin) are still largely in use. bApproximate date, mainly adapted fromPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DbGF0d29ydGh5PC9BdXRob3I+PFllYXI+MjAwNzwvWWVh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==
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DbGF0d29ydGh5PC9BdXRob3I+PFllYXI+MjAwNzwvWWVh
cj48UmVjTnVtPjY2PC9SZWNOdW0+PERpc3BsYXlUZXh0PihDbGF0d29ydGh5IGV0IGFsIDIwMDcs
IHZhbiBIb2VrIGV0IGFsIDIwMTEpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjY2
PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0id3p3OWZzd2Zw
dzA5eDdlcHp3ZHYyd3BydnR6cnJkdHNhdDVwIiB0aW1lc3RhbXA9IjE0OTk0Mjk2NzAiPjY2PC9r
ZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3Jl
Zi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5DbGF0d29ydGh5LCBBLiBFLjwv
YXV0aG9yPjxhdXRob3I+UGllcnNvbiwgRS48L2F1dGhvcj48YXV0aG9yPkh1bmcsIEQuIFQuPC9h
dXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBv
ZiBNb2xlY3VsYXIgQmlvbG9neSBhbmQgQ2VudGVyIGZvciBDb21wdXRhdGlvbmFsIGFuZCBJbnRl
Z3JhdGl2ZSBCaW9sb2d5LCBNYXNzYWNodXNldHRzIEdlbmVyYWwgSG9zcGl0YWwsIDE4NSBDYW1i
cmlkZ2UgU3QuLCBCb3N0b24sIE1hc3NhY2h1c2V0dHMgMDIxMTQsIFVTQS48L2F1dGgtYWRkcmVz
cz48dGl0bGVzPjx0aXRsZT5UYXJnZXRpbmcgdmlydWxlbmNlOiBhIG5ldyBwYXJhZGlnbSBmb3Ig
YW50aW1pY3JvYmlhbCB0aGVyYXB5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPk5hdCBDaGVtIEJp
b2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5OYXQg
Q2hlbSBCaW9sPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+NTQxLTg8L3BhZ2VzPjx2
b2x1bWU+Mzwvdm9sdW1lPjxudW1iZXI+OTwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BbnRp
LUluZmVjdGl2ZSBBZ2VudHMvKnBoYXJtYWNvbG9neS90aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+
PGtleXdvcmQ+QmFjdGVyaWFsIEFkaGVzaW9uL2RydWcgZWZmZWN0czwva2V5d29yZD48a2V5d29y
ZD5EcnVnIERlbGl2ZXJ5IFN5c3RlbXM8L2tleXdvcmQ+PGtleXdvcmQ+R2VuZXMsIEJhY3Rlcmlh
bDwva2V5d29yZD48a2V5d29yZD5RdW9ydW0gU2Vuc2luZy9kcnVnIGVmZmVjdHM8L2tleXdvcmQ+
PGtleXdvcmQ+VmlydWxlbmNlLypkcnVnIGVmZmVjdHMvZ2VuZXRpY3M8L2tleXdvcmQ+PGtleXdv
cmQ+VmlydWxlbmNlIEZhY3RvcnMvKmFudGFnb25pc3RzICZhbXA7IGluaGliaXRvcnM8L2tleXdv
cmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwNzwveWVhcj48cHViLWRhdGVzPjxkYXRlPlNl
cDwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1NTItNDQ1MCAoUHJpbnQpJiN4RDsx
NTUyLTQ0NTAgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjE3NzEwMTAwPC9hY2Nlc3Np
b24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwczovL3d3dy5uY2JpLm5sbS5uaWgu
Z292L3B1Ym1lZC8xNzcxMDEwMDwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25p
Yy1yZXNvdXJjZS1udW0+MTAuMTAzOC9uY2hlbWJpby4yMDA3LjI0PC9lbGVjdHJvbmljLXJlc291
cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj52YW4gSG9lazwvQXV0aG9yPjxZ
ZWFyPjIwMTE8L1llYXI+PFJlY051bT42NzwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+Njc8
L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJ3enc5ZnN3ZnB3
MDl4N2VwendkdjJ3cHJ2dHpycmR0c2F0NXAiIHRpbWVzdGFtcD0iMTQ5OTQyOTc0NiI+Njc8L2tl
eT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVm
LXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPnZhbiBIb2VrLCBBLiBILjwvYXV0
aG9yPjxhdXRob3I+TWV2aXVzLCBELjwvYXV0aG9yPjxhdXRob3I+R3VlcnJhLCBCLjwvYXV0aG9y
PjxhdXRob3I+TXVsbGFueSwgUC48L2F1dGhvcj48YXV0aG9yPlJvYmVydHMsIEEuIFAuPC9hdXRo
b3I+PGF1dGhvcj5BYXJ0cywgSC4gSi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+
PGF1dGgtYWRkcmVzcz5MYWJvcmF0b3J5IGZvciBab29ub3NlcyBhbmQgRW52aXJvbm1lbnRhbCBN
aWNyb2Jpb2xvZ3ksIENlbnRyZSBmb3IgSW5mZWN0aW91cyBEaXNlYXNlIENvbnRyb2wsIE5hdGlv
bmFsIEluc3RpdHV0ZSBvZiBQdWJsaWMgSGVhbHRoIGFuZCB0aGUgRW52aXJvbm1lbnQgVXRyZWNo
dCwgTmV0aGVybGFuZHMuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+QWNxdWlyZWQgYW50
aWJpb3RpYyByZXNpc3RhbmNlIGdlbmVzOiBhbiBvdmVydmlldzwvdGl0bGU+PHNlY29uZGFyeS10
aXRsZT5Gcm9udCBNaWNyb2Jpb2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNh
bD48ZnVsbC10aXRsZT5Gcm9udCBNaWNyb2Jpb2w8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxw
YWdlcz4yMDM8L3BhZ2VzPjx2b2x1bWU+Mjwvdm9sdW1lPjxrZXl3b3Jkcz48a2V5d29yZD5hY3F1
aXJlZDwva2V5d29yZD48a2V5d29yZD5hbnRpYmlvdGljczwva2V5d29yZD48a2V5d29yZD5hbnRp
bWljcm9iaWFsIHJlc2lzdGFuY2UgbWVjaGFuaXNtczwva2V5d29yZD48a2V5d29yZD5tb2JpbGUg
Z2VuZXRpYyBlbGVtZW50czwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDExPC95
ZWFyPjwvZGF0ZXM+PGlzYm4+MTY2NC0zMDJYIChFbGVjdHJvbmljKSYjeEQ7MTY2NC0zMDJYIChM
aW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMjA0NjE3MjwvYWNjZXNzaW9uLW51bT48dXJs
cz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQv
MjIwNDYxNzI8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGN1c3RvbTI+UE1DMzIwMjIyMzwv
Y3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMzM4OS9mbWljYi4yMDExLjAwMjAz
PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==
ADDIN EN.CITE.DATA (Clatworthy et al 2007, van Hoek et al 2011). The year of resistance documentation is often much earlier than the year of the description of the mechanism leading to a resistance phenotype. For example for aminoglycosides, the first identified resistance mechanism was the decreased permeability, which was initially described only in vitro.cWith the availability of cotrimoxazole since 1968, there has been an increased use of cotrimoxazole until about 1985, when 2nd generation quinolones (such as ciprofloxacine) have been largely available.dRecent increase in use of penicillin instead of methicillin or cephalosporins for susceptible strains in order to attempt to reduce selection pressure due to overuse of antibiotics.eIncluding its use in combination with clavulanate.fSuccessive discovery of first- second- and third generation of cephalosporins. gThere is still a wide use of cephalosporins in Switzerland nowadays, mainly ceftriaxone for the treatment of severe infections due to Gram negative bacteremia, including E. coli bacteremia, which represents the most common cause of bacteremia (mainly in the setting of urosepsis). hAfter a first wide use of vancomycin in initial empirical therapy, especially for severe infections such as endocarditis, bacteremia and fever in neutropenic subjects, the use of vancomycin slightly decreased due to concern about emerging resistance in enterococci; use of vancomycin then again increased due to surge in prevalence of methicillin-resistant Staphylococcus aureus (MRSA) and then due to common vancomycin-resistant enterococci (VRE).iLarger usage of macrolides when clarithromycin and azithromycin have been made available, especially for the empirical treatment of lower respiratory tract infections (in combination with cephalosporins, when severe)jNorfloxacin was largely replaced by ciprofloxacin as first line treatment for urinary tract infection from 1995 onwards, due to concern regarding antibiotic resistance and improved efficacy of ciprofloxacin for complicated urinary tract infections; in 2008, the European Medicines Agency recommended to avoid using oral norfloxacin for treatment of urinary infections () kCiprofloxacin largely replaced norfloxacin for urinary tract infection from 1995 to 2005; in addition from 1990 to 2000, ciprofloxacin was largely used for the empirical treatment of lower respiratory tract infections?(LRTI); then due to increased concern about resistance, cotrimoxazole was proposed as first-line empirical antibiotic treatment for uncomplicated urinary tract infection and macrolides replaced quinolones in the treatment of LRTI. This change for a decreasing usage of quinolones was also triggered by the decreased rate of susceptible Gram-negative bacilli to quinolones, which decreased from about 90% in 1990 to about 65-70% in 2000 in USA and in Europe. lMainly used to treat staphylococcal infections from 1965 to 1975; however, its usage has declined much due to documentation of resistance and due to possible increased risk of post-antibiotic colitis due the broad antimicrobial effect of clindamycin on anaerobes, which constitute more than 90% of the intestinal microbiota. ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
Related searches
- personal financial management marine net pdf
- company net worth lookup
- comenity net dental first financing
- marine net financial management pdf
- amazon net sales 2017
- average net profit small business
- amazon net profit 2018
- marine net personal finance answers
- hong kong net scheme
- business net worth lookup
- free net worth search
- company net worth search